Fig. 7From: Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinomaVerification of the expression and prognostic value of RFX5 in STAD. A The immunohistochemistry of RFX5 in STAD tissues and gastric tissues. B, C The mRNA level and prognostic value of RFX5 in STAD. D, E Univariate and multivariate cox regression analysis considering RFX5 expression and clinicopathologic features in STAD. STAD, stomach adenocarcinomaBack to article page